AC
CYTO

Armistice Capital’s Altamira Therapeutics Ltd CYTO Stock Holding History

Armistice Capital’s Portfolio CYTO Stock Details CYTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-101,444
Closed -$61.9K – 319
2024
Q3 		$61.9K Buy
+101,444
New +$101K ﹤0.01% 240
2023
Q4 		– Sell
-41,450
Closed -$203K – 368
2023
Q3 		$203K Buy
+41,450
New +$294K ﹤0.01% 202

Other funds holding CYTO

XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Armistice Capital's CYTO Position: Q4 2024 in Review

Armistice Capital sold out of Altamira Therapeutics Ltd (CYTO) in Q4 2024, closing a stake of 101,444 shares — an estimated $61.9K sold.

Armistice Capital first reported a position in CYTO in Q3 2023 and held it in 2 quarters. The position peaked at $203K in Q3 2023. 2 funds tracked by Wall St. Rank hold CYTO as of Q4 2024.

  • Armistice Capital reported no remaining Altamira Therapeutics Ltd position as of Q4 2024 after selling out during the quarter.
  • Armistice Capital sold 101,444 Altamira Therapeutics Ltd shares in Q4 2024, an estimated $61.9K.
  • Armistice Capital first reported a position in Altamira Therapeutics Ltd in Q3 2023 and held it in 2 quarters.
  • Armistice Capital's Altamira Therapeutics Ltd position peaked at $203K in Q3 2023.
  • 2 funds tracked by Wall St. Rank held Altamira Therapeutics Ltd as of Q4 2024.

Based on Armistice Capital's 13F filing for Q4 2024, filed 14 Feb 2025.